Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study. https://t.co/RNJBMig5GO H/T @NCBI #radonc #PubMed
RT @multimmune: multimmune's autologous NK cell therapy followed by second-line PD-1 inhibition delivers long-term disease control in patie…
RT @multimmune: multimmune's autologous NK cell therapy followed by second-line PD-1 inhibition delivers long-term disease control in patie…
multimmune's autologous NK cell therapy followed by second-line PD-1 inhibition delivers long-term disease control in patient with lung cancer: https://t.co/6ryUCmMwoo https://t.co/smQD5keSTS https://t.co/9CZrZY0owG
RT @multimmune: Long-term control of lung cancer in patient treated with ENKASTIM NK cell therapy followed by second-line PD-1 inhibition:…
Long-term control of lung cancer in patient treated with ENKASTIM NK cell therapy followed by second-line PD-1 inhibition: https://t.co/mXibxleZw5 https://t.co/smQD5keSTS https://t.co/MrNqW5gXXK
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study. https://t.co/3rjcM7UMyX
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study. by Kokowski K, Stangl S, Seier S, Hildebrandt M, Vaupel P, Multhoff G https://t.co/